Trials / Completed
CompletedNCT02966145
4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2
The Four-Repeat Tauopathy Neuroimaging Initiative
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 293 (actual)
- Sponsor
- University of California, San Francisco · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to identify the most reliable methods of analysis for tracking CBD, PSP, and o/vPSP over time. The results from this study may be used in the future to calculate statistical power for clinical drug trials. The study will also provide information about the relative value of novel imaging techniques for diagnosis, as well as the value of imaging techniques versus testing of blood, urine, and cerebrospinal fluid (CSF) 'biomarkers'.
Conditions
- Corticobasal Degeneration (CBD)
- Corticobasal Syndrome (CBS)
- Cortical-basal Ganglionic Degeneration (CBGD)
- Progressive Supranuclear Palsy (PSP)
- Nonfluent Variant Primary Progressive Aphasia (nfvPPA)
- Oligosymptomatic/Variant Progressive Supranuclear Palsy (o/vPSP)
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observational Study |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2024-02-28
- Completion
- 2024-02-28
- First posted
- 2016-11-17
- Last updated
- 2025-04-13
Locations
8 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT02966145. Inclusion in this directory is not an endorsement.